This is in contrast to the RTOG 9413 trial in which radiation during testosterone flare was avoided and providing ADT before or after radiation did not result in any significant difference in survival [58]. Figure 3. Prostate cancer treatment with luteinizing hormone-releasing hormone (LHRH), ...